ANAB
ANAPTYSBIO, INC
NASDAQ · Healthcare · Biotechnology · US
$55.20
+0.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 18.93x
- P/E 2028E
- 8.64x
- P/S forward
- 27.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 128.22x
- Price / sales
- 7.03x
- Price / cash flow
- 364.98x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 6.99x
- EV / EBITDA
- 27.79x
- EV / EBIT
- 39.84x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026